LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 62 filers reported holding LYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $317 | +37.8% | 50,900 | +15.9% | 0.00% | – |
| Q4 2023 | $230 | +17.9% | 43,900 | -11.8% | 0.00% | – |
| Q3 2023 | $195 | -33.2% | 49,800 | -29.9% | 0.00% | – |
| Q2 2023 | $292 | +204.2% | 71,000 | +48.4% | 0.00% | – |
| Q1 2023 | $96 | -17.9% | 47,851 | +28.6% | 0.00% | – |
| Q4 2022 | $117 | -99.9% | 37,200 | -7.0% | 0.00% | – |
| Q3 2022 | $200,000 | -13.8% | 40,000 | -2.4% | 0.00% | – |
| Q2 2022 | $232,000 | +231.4% | 41,000 | +134.3% | 0.00% | – |
| Q1 2022 | $70,000 | -69.2% | 17,500 | -66.3% | 0.00% | – |
| Q4 2021 | $227,000 | – | 52,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
| Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
| Clearline Capital LP | 119,924 | $482,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
| Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
| Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |